Global Seasonal Affective Disorder Market Growth (Status and Outlook) 2023-2029

Global Seasonal Affective Disorder Market Growth (Status and Outlook) 2023-2029

Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between the ages of 15 to 55, and the people who live far from the equator where winter daylight hours are too short. Some major symptoms of this disorder are hopelessness, increased appetite, weight gain, loss of the ability to concentrate, social withdrawal etc. There are some risk factors associated with this disorder such as major depressive disorder, Bipolar I disorder, Bipolar II disorder, and others.

LPI (LP Information)' newest research report, the “Seasonal Affective Disorder Industry Forecast” looks at past sales and reviews total world Seasonal Affective Disorder sales in 2022, providing a comprehensive analysis by region and market sector of projected Seasonal Affective Disorder sales for 2023 through 2029. With Seasonal Affective Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Seasonal Affective Disorder industry.

This Insight Report provides a comprehensive analysis of the global Seasonal Affective Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Seasonal Affective Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Seasonal Affective Disorder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Seasonal Affective Disorder and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Seasonal Affective Disorder.

The global Seasonal Affective Disorder market size is projected to grow from US$ 519.5 million in 2022 to US$ 616.2 million in 2029; it is expected to grow at a CAGR of 2.5% from 2023 to 2029.

The Americas hold the largest share in the global Seasonal affective disorder market. North America dominates the market in this region. Approximately 5% of the US population is suffering from seasonal depression Some other factors such as changing lifestyle plays an important role in market growth. South America market is also growing significantly, especially growth is higher in countries such as Brazil due to increasing awareness about various mental disorders.

This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Affective Disorder market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Light Therapy
Medications
Others

Segmentation by application
Hospital
Clinic
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie Inc. (US)
Allergan (Republic of Ireland)
Bayer AG (Germany)
Bristol-Myers Squibb Company (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Henry Schein(US)
Pfizer Inc. (US)

Please note: The report will take approximately 2 business days to prepare and deliver.